AUD/USD Price Forecast: Stuck between key SMAs, RSI turns bearish
The AUD/USD edges lower during the North American session, poised to remain sideways within key technical support and resistance levels, with the 20-day Simple Moving Average (SMA) at 0.7187 and the 50-day SMA at 0.7095. At the time of writing, the pair is trading around 0.7137, down 0.17%.
AUD/USD Price Forecast: Technical outlook
From a technical perspective, the AUD/USD market structure suggests further downside if the pair falls below the April 29 swing low at 0.7101, reaching a 4-week low at 0.7079 on May 19.
The Relative Strength Index (RSI) turned bearish, signaling that sellers are gaining momentum, as it fell below its 50-neutral level.
For a bearish resumption, the AUD/USD must clear the May 21 low at 0.7099, so traders can test the 50-day SMA. On further weakness, the 100-day SMA at 0.7024 becomes the next support level, followed by 0.7000.
On the upside, a break above the 20-day SMA will expose the 0.7200 milestone. Above this area, the next resistance is the year-to-date (YTD) peak at 0.7264.
AUD/USD Price Chart – Daily
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
RNA therapy company Adarx Pharmaceuticals (ADRX.US) plans to raise up to $372 million in a U.S. IPO; pharmaceutical giant AbbVie (ABBV.US) has agreed to invest up to $100 million
RNA therapy company Adarx Pharmaceuticals, which is in the late stage of clinical development, plans to raise up to $371.9 million through its initial public offering (IPO) in the United States.
Ledger CTO urges crypto holders to update iPhones after DarkSword exploit revealed
Crypto ICOs Left in Limbo After CLARITY Act Fails in Senate
